Global High Potency API /HPAPI Market
The global High Potency API /HPAPI market was valued at USD 16 billion in 2016 and is projected to reach USD 33.15 billion by 2025, growing at a CAGR of 8.43% from 2017 to 2025.
A significant proportion of new drugs under development contain high-potency active pharmaceutical ingredients (HPAPIs), which is leading to explosive growth in demand for their production. The cytotoxicity of the drugs and high capital required can be possible restrains for the market.
1. Market Drivers
1.1 Increasing scope of oncology drug market
1.2 Increase in demand of antibody based drugs
1.3 Technological advancements in HPAPI
1.4 Interest In HPAPI by major players
2. Market Restraints
2.1 High initial investments
2.2 Stringent regulations
1. By Therapeutic Application:
1.2 Hormonal Imbalance
1.4 Other Therapeutic Applications
2. By Type of manufacturers:
2.1 Captive Manufacturers
2.2 Merchant Manufacturers
2.3 Merchant HPAPI Manufacturers Market, By Type
2.3.1 Innovative Merchant HPAPI Manufacturers
2.3.2 Generic Merchant HPAPI Manufacturers
2.4 Merchant HPAPI Manufacturers Market, By Type of Synthesis
2.4.1 Synthetic HPAPIs
2.4.2 Biotech HPAPIs
3. By Type of Synthesis:
3.1 Synthetic High Potency Active Pharmaceutical Ingredients
3.2 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type
3.2.1 Innovative Synthetic HPAPIs
3.2.2 Generic Synthetic HPAPIs
3.3 Biotech High Potency Active Pharmaceutical Ingredients
3.3.1 Biotech High- potency Active Pharmaceutical Ingredients Market, By Type
220.127.116.11 Innovative Biotech HPAPIs
4. By Type:
4.1 Innovative High Potency Active Pharmaceutical Ingredients
4.2 Generic High Potency Active Pharmaceutical Ingredients
5. By Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
The major players in the market are as follows:
1. Pfizer, Inc.
2. Novartis International AG
4. F. Hoffmann-La Roche Ltd.
5. Bristol-Myers Squibb
7. Teva Pharmaceutical Industries Ltd.
8. ELI Lilly and Company
9. Merck & Co., Inc.
10. Abbvie Inc.
11. Mylan N.V.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the High Potency API /HPAPImarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.